Evolution-adjusted Tumor Pathophysiology: The Novel Language of Tumor Biology

Evolution-adjusted Tumor Pathophysiology: The Novel Language of Tumor Biology

Reichle, Albrecht

155,99 €(IVA inc.)

Combined modularized therapies for metastatic cancer are pointing to central problems of communication among ‘systems participators’. A communication theory explains 'social engineering', endogenously induced or by implementing non-normative boundary conditions. Evolution-adjusted tumor pathophysiology is borne by an evolution theory, which contrasts narrative evolution histories. The tool of rationalizations constituting the tumor's normativity (inflammation, immune response etc.) represents the non-genomic counterpart of the tumor genome and should be additionally assessed during tumor staging. Evolution-adjusted tumor pathophysiology allows implementing applied systems biology, a novel clinical and pharmaceutical technology for bioengineering tumor response and personalizing tumor therapy. Combined modularized therapy, evolution-adjusted tumor pathophysiology, and ‘universal’ biomarkers concertedly address genetically based tumor heterogeneity.

  • ISBN: 978-94-007-9787-1
  • Editorial: Springer
  • Encuadernacion: Rústica
  • Fecha Publicación: 08/08/2015
  • Nº Volúmenes: 1
  • Idioma: Inglés